| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SLRN | ACELYRIN, Inc. | Harper Sean E | 10% Owner | May 09, 2023 | Buy | $18.00 | 1,250,000 | 22,500,000 | 9,790,729 | May 11, 2023, 09:16 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Jul 16, 2018 | Sale | $195.71 | 1,525 | 298,458 | 56,082 | Jul 16, 2018, 08:20 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Jun 12, 2018 | Sale | $184.27 | 1,525 | 281,012 | 57,510 | Jun 12, 2018, 07:07 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | May 14, 2018 | Sale | $174.10 | 1,525 | 265,503 | 59,035 | May 15, 2018, 07:52 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | May 03, 2018 | Option Exercise | $169.43 | 736 | 124,700 | 60,560 | May 07, 2018, 06:58 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Apr 12, 2018 | Sale | $172.68 | 1,525 | 263,337 | 56,788 | Apr 16, 2018, 07:03 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Mar 23, 2018 | Option Exercise | $176.08 | 7,549 | 1,329,228 | 58,313 | Mar 27, 2018, 07:40 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Mar 16, 2018 | Sale | $189.75 | 1,525 | 289,369 | 65,682 | Mar 19, 2018, 08:52 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Feb 14, 2018 | Sale | $174.18 | 1,525 | 265,624 | 52,089 | Feb 15, 2018, 08:57 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Jan 30, 2018 | Option Exercise | $198.00 | 453 | 89,694 | 54,200 | Feb 01, 2018, 08:35 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Jan 31, 2018 | Option Exercise | $191.27 | 606 | 115,910 | 53,614 | Feb 01, 2018, 08:35 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Jan 16, 2018 | Sale | $185.62 | 1,525 | 283,070 | 54,673 | Jan 17, 2018, 08:19 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Dec 12, 2017 | Sale | $176.83 | 1,525 | 269,666 | 56,106 | Dec 12, 2017, 08:24 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Nov 13, 2017 | Sale | $171.58 | 1,525 | 261,660 | 57,631 | Nov 14, 2017, 07:27 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Oct 09, 2017 | Sale | $185.95 | 1,525 | 283,574 | 59,156 | Oct 10, 2017, 08:29 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Mar 24, 2017 | Option Exercise | $166.04 | 12,128 | 2,013,733 | 55,945 | Mar 28, 2017, 06:54 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Jan 31, 2017 | Option Exercise | $154.43 | 668 | 103,159 | 44,774 | Feb 02, 2017, 06:59 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Jan 28, 2017 | Option Exercise | $157.16 | 1,056 | 165,961 | 45,955 | Jan 31, 2017, 07:08 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Jan 30, 2017 | Option Exercise | $157.16 | 513 | 80,623 | 45,442 | Jan 31, 2017, 07:08 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Apr 29, 2016 | Sale | $157.99 | 21,875 | 3,456,141 | 42,248 | May 03, 2016, 07:14 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Apr 27, 2016 | Option Exercise | $162.85 | 1,659 | 270,168 | 64,123 | Apr 29, 2016, 07:43 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Mar 25, 2016 | Option Exercise | $149.24 | 23,785 | 3,549,674 | 65,782 | Mar 29, 2016, 05:09 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Jan 28, 2016 | Option Exercise | $150.47 | 999 | 150,320 | 44,281 | Feb 01, 2016, 08:29 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Jan 31, 2016 | Option Exercise | $152.73 | 651 | 99,427 | 43,894 | Feb 01, 2016, 08:29 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Apr 25, 2015 | Option Exercise | $167.91 | 1,065 | 178,824 | 46,855 | Apr 28, 2015, 07:58 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Apr 27, 2015 | Option Exercise | $167.91 | 1,575 | 264,458 | 45,280 | Apr 28, 2015, 07:58 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Apr 22, 2015 | Sale | $171.58 | 28,000 | 4,804,240 | 47,920 | Apr 23, 2015, 05:04 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Mar 27, 2015 | Option Exercise | $160.55 | 28,624 | 4,595,583 | 75,920 | Mar 31, 2015, 06:47 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Jan 28, 2015 | Option Exercise | $158.89 | 963 | 153,011 | 45,680 | Jan 30, 2015, 04:56 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Dec 31, 2014 | Option Exercise | $160.63 | 13,046 | 2,095,579 | 46,608 | Jan 05, 2015, 04:22 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Aug 05, 2014 | Sale | $127.29 | 14,000 | 1,782,130 | 59,503 | Aug 07, 2014, 04:22 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Apr 25, 2014 | Option Exercise | $113.72 | 1,034 | 117,586 | 75,554 | Apr 29, 2014, 05:42 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Apr 26, 2014 | Option Exercise | $111.41 | 601 | 66,957 | 74,953 | Apr 29, 2014, 05:42 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Apr 27, 2014 | Option Exercise | $111.41 | 1,546 | 172,240 | 73,463 | Apr 29, 2014, 05:42 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Mar 14, 2014 | Option Exercise | $123.96 | 7,683 | 952,385 | 76,588 | Mar 18, 2014, 04:26 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | May 02, 2013 | Option Exercise | $50.44 | 8,000 | 403,520 | 72,180 | May 06, 2013, 05:27 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | May 02, 2013 | Sale | $106.32 | 8,000 | 850,592 | 64,180 | May 06, 2013, 05:27 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Apr 26, 2013 | Option Exercise | $108.66 | 601 | 65,305 | 64,768 | Apr 30, 2013, 05:18 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Apr 28, 2013 | Option Exercise | $108.38 | 588 | 63,727 | 64,180 | Apr 30, 2013, 05:18 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Apr 25, 2013 | Option Exercise | $104.93 | 1,034 | 108,498 | 65,369 | Apr 29, 2013, 06:04 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Mar 15, 2013 | Option Exercise | $92.18 | 6,918 | 637,701 | 66,403 | Mar 19, 2013, 07:43 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Jul 27, 2012 | Option Exercise | $68.43 | 39,900 | 2,730,172 | 84,332 | Jul 31, 2012, 07:35 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Jul 27, 2012 | Sale | $82.33 | 39,900 | 3,285,087 | 52,432 | Jul 31, 2012, 07:35 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | May 03, 2012 | Option Exercise | $71.17 | 11,453 | 815,110 | 59,145 | May 03, 2012, 09:13 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | May 03, 2012 | Option Exercise | $46.88 | 14,000 | 656,300 | 63,840 | May 03, 2012, 09:13 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Apr 28, 2012 | Option Exercise | $71.64 | 526 | 37,683 | 52,385 | May 01, 2012, 08:51 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Apr 29, 2012 | Option Exercise | $71.64 | 2,545 | 182,324 | 49,840 | May 01, 2012, 08:51 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Apr 26, 2012 | Option Exercise | $70.19 | 514 | 36,078 | 44,257 | Apr 30, 2012, 05:12 PM | |
| AMGN | AMGEN INC | Harper Sean E | EVP, Research & Development | Mar 16, 2012 | Option Exercise | $68.26 | 1,519 | 103,687 | 44,771 | Mar 20, 2012, 05:50 PM |
Menu